We are live on
!
Find out more
SGA
Sector Gamma AS Portfolio holdings
AUM
$423M
1-Year Est. Return
17.56%
This Fund
S&P 500
This Quarter
Est. Return
+5.88%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$343M
AUM Growth
–
Cap. Flow
+$338M
Cap. Flow
% of AUM
98.62%
Top 10 Holdings %
Top 10 Hldgs %
63.2%
Holding
33
New
33
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$34.9M |
| 2 |
Johnson & Johnson
JNJ
|
+$32.7M |
| 3 |
Boston Scientific
BSX
|
+$30.2M |
| 4 |
Eli Lilly
LLY
|
+$29.7M |
| 5 |
Cardinal Health
CAH
|
+$18.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 80.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRX
1
DELISTED
FOREST LABORATORIES INC
FRX
| $37M | 10.79% |
+902,000
| New | +$34.9M |
|
|
2
Johnson & Johnson
JNJ
$609B
| $33.1M | 9.65% |
+385,500
| New | +$32.7M |
|
|
3
Boston Scientific
BSX
$65.4B
| $33M | 9.62% |
+3,557,000
| New | +$30.2M |
|
|
4
Eli Lilly
LLY
$1.05T
| $26.8M | 7.81% |
+545,407
| New | +$29.7M |
|
|
5
Cardinal Health
CAH
$53.5B
| $19.2M | 5.59% |
+406,000
| New | +$18.5M |
|
6
Baxter International
BAX
$11.7B
| $17.8M | 5.18% |
+472,217
| New | +$18.1M |
|
|
CBST
7
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $14M | 4.08% |
+289,442
| New | +$14.2M |
|
8
Teva Pharmaceuticals
TEVA
$37.3B
| $13.3M | 3.88% |
+339,000
| New | +$13.2M |
|
|
AUXL
9
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $11.4M | 3.32% |
+684,724
| New | +$10.9M |
|
|
ONXX
10
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $11.3M | 3.29% |
+129,815
| New | +$12M |
|
11
Illumina
ILMN
$28.2B
| $9.8M | 2.86% |
+134,668
| New | +$8.62M |
|
|
SLXP
12
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $9.72M | 2.84% |
+147,001
| New | +$8.41M |
|
|
HSP
13
DELISTED
HOSPIRA INC
HSP
| $8.73M | 2.55% |
+228,000
| New | +$7.71M |
|
|
MDCO
14
DELISTED
Medicines Co
MDCO
| $8.45M | 2.46% |
+274,750
| New | +$9.19M |
|
|
MASI
15
DELISTED
Masimo
MASI
| $8.18M | 2.39% |
+385,991
| New | +$8.12M |
|
16
Revvity
RVTY
$12.3B
| $7.87M | 2.29% |
+242,000
| New | +$7.92M |
|
17
Vertex Pharmaceuticals
VRTX
$123B
| $7.63M | 2.23% |
+95,300
| New | +$7.02M |
|
|
LPNT
18
DELISTED
LifePoint Health, Inc.
LPNT
| $7.22M | 2.11% |
+147,800
| New | +$7.09M |
|
|
ESRX
19
DELISTED
Express Scripts Holding Company
ESRX
| $6.98M | 2.03% |
+113,000
| New | +$6.8M |
|
20
ResMed
RMD
$28.9B
| $6.4M | 1.87% |
+141,770
| New | +$6.73M |
|
21
Agilent Technologies
A
$37.1B
| $6.33M | 1.85% |
+206,904
| New | +$6.43M |
|
|
THOR
22
DELISTED
THORATEC CORPORATION
THOR
| $6.26M | 1.83% |
+200,000
| New | +$6.71M |
|
|
SHPG
23
DELISTED
Shire pic
SHPG
| $5.71M | 1.66% |
+60,000
| New | +$5.62M |
|
|
OPTR
24
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
| $4.94M | 1.44% |
+341,393
| New | +$4.97M |
|
|
ACH
25
Accendra Health
ACH
$266M
| $4.71M | 1.38% |
+139,384
| New | +$4.63M |
|
Similar funds
AFWM
MP
DS
RS
DF
OGM
CPIM
MPPLM
Sector Gamma AS's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Sector Gamma AS, which disclosed 33 positions worth $343M. Its ten largest holdings account for 63% of the portfolio.
Its largest position is FOREST LABORATORIES INC: 902,000 shares worth $37M.
By sector, the portfolio is most concentrated in Healthcare at 80% of assets.
- Sector Gamma AS's largest Q2 2013 buy was FOREST LABORATORIES INC: 902,000 shares worth $37M.
- Sector Gamma AS's ten largest holdings make up 63% of its $343M portfolio in Q2 2013.
- Sector Gamma AS disclosed 33 positions in Q2 2013, its first 13F filing on record.
Based on Sector Gamma AS's 13F filing for Q2 2013, filed 14 Aug 2013.